Literature DB >> 14566868

pH-sensitive modulation of the second hydration sphere in lanthanide(III) tetraamide-DOTA complexes: a novel approach to smart MR contrast media.

Mark Woods1, Shanrong Zhang, Von Howard Ebron, A Dean Sherry.   

Abstract

The lanthanide(III) complexes of three tetraamide DOTA bearing pyridyl, phenolic and hydroxypyridyl substituents have been studied by NMR, luminescence and cyclic voltammetry. The relaxivity profiles of the gadolinium complexes of the pyridyl and phenolic ligands were flat and essentially the same between pH 2 and 8. The hydroxypyridyl ligand, however, exhibited two regions of enhanced relaxivity. The small relaxivity enhancement (25 %) at lower pH (pH 2-4) has been attributed to an increase in the prototropic exchange of the coordinated water molecule while the slightly larger enhancement (84 %) at higher pH (pH 6-9) reflects deprotonation of the ligand amide protons. Deprotonation of the amides results in the formation of an intramolecular acid-base pair interaction with the phenolic protons and this, in turn, causes a highly organized second hydration sphere to come into effect, thereby increasing the relaxivity. The water relaxivity of the Gd(3+)-hydroxypyridyl complex is further enhanced upon binding to serum albumin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566868     DOI: 10.1002/chem.200305159

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  20 in total

1.  Toward the Design of MR Agents for Imaging β-Cell Function.

Authors:  Mark Woods; Shanrong Zhang; A Dean Sherry
Journal:  Curr Med Chem Immunol Endocr Metab Agents       Date:  2004-12

Review 2.  Alternatives to gadolinium-based metal chelates for magnetic resonance imaging.

Authors:  Subha Viswanathan; Zoltan Kovacs; Kayla N Green; S James Ratnakar; A Dean Sherry
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Activation of a PARACEST agent for MRI through selective outersphere interactions with phosphate diesters.

Authors:  Ching-Hui Huang; Jacob Hammell; S James Ratnakar; A Dean Sherry; Janet R Morrow
Journal:  Inorg Chem       Date:  2010-07-05       Impact factor: 5.165

Review 4.  Synthetic approaches to heterocyclic ligands for Gd-based MRI contrast agents.

Authors:  Elena Pérez-Mayoral; Jordi Soler-Padrós; Viviana Negri; Sebastián Cerdán; Paloma Ballesteros
Journal:  Molecules       Date:  2007-08-09       Impact factor: 4.411

5.  Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent.

Authors:  M Meser Ali; Mark Woods; Peter Caravan; Ana C L Opina; Marga Spiller; James C Fettinger; A Dean Sherry
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

6.  Structural and chiroptical properties of the two coordination isomers of YbDOTA-type complexes.

Authors:  Lorenzo Di Bari; Gennaro Pescitelli; A Dean Sherry; Mark Woods
Journal:  Inorg Chem       Date:  2005-11-14       Impact factor: 5.165

7.  The population of SAP and TSAP isomers in cyclen-based lanthanide(III) chelates is substantially affected by solvent.

Authors:  Kyle J Miller; Ali A Saherwala; Benjamin C Webber; Yunkou Wu; A Dean Sherry; Mark Woods
Journal:  Inorg Chem       Date:  2010-10-04       Impact factor: 5.165

8.  The effect of regioisomerism on the coordination chemistry and CEST properties of lanthanide(III) NB-DOTA-tetraamide chelates.

Authors:  Jacqueline R Slack; Mark Woods
Journal:  J Biol Inorg Chem       Date:  2013-11-28       Impact factor: 3.358

9.  Towards extracellular Ca2+ sensing by MRI: synthesis and calcium-dependent 1H and 17O relaxation studies of two novel bismacrocyclic Gd3+ complexes.

Authors:  Kirti Dhingra; Petra Fousková; Goran Angelovski; Martin E Maier; Nikos K Logothetis; Eva Tóth
Journal:  J Biol Inorg Chem       Date:  2007-09-15       Impact factor: 3.358

Review 10.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.